Emily Anne Ferenczi, B.M.,B.Ch.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Encephalomalacia | 1 | 2018 | 18 | 0.630 |
Why?
|
| Delusions | 1 | 2020 | 298 | 0.590 |
Why?
|
| Frontotemporal Dementia | 1 | 2020 | 246 | 0.560 |
Why?
|
| Face | 1 | 2022 | 1017 | 0.520 |
Why?
|
| Lighting | 1 | 2016 | 211 | 0.460 |
Why?
|
| Ion Pumps | 1 | 2012 | 15 | 0.420 |
Why?
|
| Corpus Striatum | 1 | 2016 | 1233 | 0.330 |
Why?
|
| Neurons | 6 | 2018 | 9416 | 0.330 |
Why?
|
| Reward | 1 | 2016 | 964 | 0.320 |
Why?
|
| Neural Inhibition | 1 | 2012 | 589 | 0.310 |
Why?
|
| Receptors, GABA-A | 1 | 2012 | 621 | 0.300 |
Why?
|
| Ammonia | 1 | 2008 | 236 | 0.290 |
Why?
|
| Prefrontal Cortex | 3 | 2016 | 2212 | 0.280 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 2008 | 465 | 0.270 |
Why?
|
| Synaptic Transmission | 1 | 2012 | 1169 | 0.260 |
Why?
|
| Motivation | 1 | 2016 | 1990 | 0.260 |
Why?
|
| Psychotic Disorders | 1 | 2020 | 3175 | 0.240 |
Why?
|
| Neural Pathways | 5 | 2016 | 3039 | 0.240 |
Why?
|
| Coma | 1 | 2008 | 487 | 0.230 |
Why?
|
| Fluid Therapy | 1 | 2007 | 593 | 0.220 |
Why?
|
| Glioblastoma | 1 | 2018 | 3482 | 0.210 |
Why?
|
| Light | 4 | 2016 | 1344 | 0.210 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2008 | 1724 | 0.190 |
Why?
|
| Facies | 1 | 2022 | 223 | 0.190 |
Why?
|
| Hippocampus | 2 | 2015 | 3737 | 0.180 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2003 | 543 | 0.180 |
Why?
|
| Opsins | 3 | 2018 | 18 | 0.170 |
Why?
|
| West Nile Fever | 2 | 2011 | 74 | 0.170 |
Why?
|
| Monitoring, Physiologic | 1 | 2007 | 1784 | 0.170 |
Why?
|
| Models, Neurological | 4 | 2016 | 1758 | 0.160 |
Why?
|
| Patch-Clamp Techniques | 2 | 2016 | 932 | 0.160 |
Why?
|
| Membrane Potentials | 2 | 2016 | 1095 | 0.150 |
Why?
|
| Brain | 5 | 2017 | 26912 | 0.150 |
Why?
|
| Myocardial Ischemia | 1 | 2008 | 2161 | 0.150 |
Why?
|
| Saimiri | 1 | 2018 | 334 | 0.140 |
Why?
|
| Brain Neoplasms | 1 | 2018 | 8984 | 0.140 |
Why?
|
| Rats, Inbred LEC | 1 | 2016 | 2 | 0.140 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2008 | 3201 | 0.130 |
Why?
|
| Implants, Experimental | 1 | 2015 | 99 | 0.120 |
Why?
|
| Fatal Outcome | 1 | 2020 | 1833 | 0.120 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2010 | 3333 | 0.120 |
Why?
|
| Nerve Net | 2 | 2018 | 2258 | 0.120 |
Why?
|
| Wireless Technology | 1 | 2015 | 98 | 0.120 |
Why?
|
| Matrix Attachment Region Binding Proteins | 1 | 2014 | 47 | 0.120 |
Why?
|
| Extracellular Space | 1 | 2016 | 565 | 0.120 |
Why?
|
| Mesencephalon | 1 | 2016 | 332 | 0.110 |
Why?
|
| Brain Chemistry | 1 | 2017 | 959 | 0.110 |
Why?
|
| Diet | 1 | 2010 | 8008 | 0.100 |
Why?
|
| CA3 Region, Hippocampal | 1 | 2012 | 54 | 0.100 |
Why?
|
| Xenopus laevis | 1 | 2016 | 964 | 0.100 |
Why?
|
| Neocortex | 1 | 2015 | 416 | 0.100 |
Why?
|
| Antibodies, Monoclonal | 1 | 2008 | 9196 | 0.100 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2016 | 2509 | 0.090 |
Why?
|
| Dopamine | 2 | 2016 | 1583 | 0.090 |
Why?
|
| Oocytes | 1 | 2016 | 1165 | 0.090 |
Why?
|
| Dentate Gyrus | 1 | 2012 | 163 | 0.090 |
Why?
|
| Horse Diseases | 1 | 2011 | 54 | 0.090 |
Why?
|
| West Nile virus | 1 | 2011 | 76 | 0.090 |
Why?
|
| Protons | 1 | 2016 | 1113 | 0.090 |
Why?
|
| Disease Outbreaks | 2 | 2011 | 1759 | 0.090 |
Why?
|
| Axons | 2 | 2018 | 1672 | 0.090 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2018 | 1032 | 0.090 |
Why?
|
| Fear | 2 | 2015 | 1462 | 0.090 |
Why?
|
| Nonlinear Dynamics | 1 | 2012 | 493 | 0.080 |
Why?
|
| Corpus Callosum | 1 | 2014 | 749 | 0.080 |
Why?
|
| tau Proteins | 1 | 2020 | 2095 | 0.080 |
Why?
|
| Animals | 15 | 2018 | 167940 | 0.080 |
Why?
|
| Fast Foods | 1 | 2010 | 210 | 0.080 |
Why?
|
| Amygdala | 1 | 2015 | 1350 | 0.070 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2008 | 231 | 0.070 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2016 | 8157 | 0.070 |
Why?
|
| Myocardial Reperfusion | 1 | 2008 | 347 | 0.070 |
Why?
|
| Spinal Cord | 1 | 2015 | 1817 | 0.070 |
Why?
|
| Myocardial Infarction | 1 | 2008 | 11891 | 0.070 |
Why?
|
| Heart Failure, Systolic | 1 | 2008 | 136 | 0.070 |
Why?
|
| HEK293 Cells | 1 | 2016 | 4264 | 0.070 |
Why?
|
| Myotonic Dystrophy | 1 | 2006 | 78 | 0.070 |
Why?
|
| Lipids | 1 | 2017 | 3336 | 0.060 |
Why?
|
| Memory | 1 | 2015 | 2179 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 4 | 2016 | 22025 | 0.060 |
Why?
|
| Professional Practice | 1 | 2007 | 313 | 0.060 |
Why?
|
| Rana temporaria | 1 | 2003 | 2 | 0.060 |
Why?
|
| Humans | 17 | 2022 | 760261 | 0.060 |
Why?
|
| Cardiovascular Diseases | 1 | 2010 | 15740 | 0.060 |
Why?
|
| Rats | 3 | 2016 | 23695 | 0.060 |
Why?
|
| Brain Ischemia | 1 | 2018 | 3127 | 0.060 |
Why?
|
| Oxygen | 1 | 2016 | 4189 | 0.060 |
Why?
|
| Hypertonic Solutions | 1 | 2003 | 82 | 0.060 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2009 | 785 | 0.060 |
Why?
|
| Sodium-Potassium-Chloride Symporters | 1 | 2003 | 104 | 0.060 |
Why?
|
| Hand Strength | 1 | 2006 | 452 | 0.060 |
Why?
|
| Video Recording | 1 | 2008 | 957 | 0.050 |
Why?
|
| Guidelines as Topic | 1 | 2009 | 1395 | 0.050 |
Why?
|
| Depressive Disorder | 1 | 2016 | 3728 | 0.050 |
Why?
|
| Calcium | 1 | 2016 | 5726 | 0.050 |
Why?
|
| Osmolar Concentration | 1 | 2003 | 662 | 0.050 |
Why?
|
| Primary Prevention | 1 | 2010 | 1207 | 0.050 |
Why?
|
| Sodium Potassium Chloride Symporter Inhibitors | 1 | 2003 | 150 | 0.050 |
Why?
|
| Dietary Fats | 1 | 2010 | 1992 | 0.050 |
Why?
|
| Infusions, Intravenous | 1 | 2007 | 2235 | 0.050 |
Why?
|
| Proteins | 1 | 2017 | 6030 | 0.050 |
Why?
|
| Cell Size | 1 | 2003 | 623 | 0.050 |
Why?
|
| Male | 12 | 2018 | 359413 | 0.050 |
Why?
|
| Medical Records | 1 | 2007 | 1407 | 0.050 |
Why?
|
| Kinetics | 2 | 2011 | 6378 | 0.050 |
Why?
|
| Calibration | 1 | 2003 | 816 | 0.050 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2003 | 477 | 0.050 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2008 | 1880 | 0.050 |
Why?
|
| Electrophysiology | 1 | 2003 | 1265 | 0.050 |
Why?
|
| Anxiety | 1 | 2015 | 4532 | 0.050 |
Why?
|
| Brain Mapping | 1 | 2016 | 6562 | 0.040 |
Why?
|
| Defibrillators, Implantable | 1 | 2010 | 1499 | 0.040 |
Why?
|
| Hungary | 2 | 2011 | 82 | 0.040 |
Why?
|
| Female | 11 | 2020 | 391011 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2008 | 8945 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2017 | 36247 | 0.040 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2008 | 1419 | 0.040 |
Why?
|
| Life Style | 1 | 2010 | 3888 | 0.040 |
Why?
|
| Risk Factors | 3 | 2018 | 74269 | 0.040 |
Why?
|
| Mice | 5 | 2017 | 81216 | 0.040 |
Why?
|
| Sodium | 1 | 2003 | 1601 | 0.040 |
Why?
|
| Risk | 1 | 2010 | 9629 | 0.040 |
Why?
|
| Cerebral Cortex | 1 | 2014 | 5755 | 0.040 |
Why?
|
| Population Surveillance | 1 | 2008 | 2609 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2008 | 6545 | 0.040 |
Why?
|
| Microscopy, Confocal | 1 | 2003 | 1972 | 0.040 |
Why?
|
| Middle Aged | 5 | 2020 | 220175 | 0.040 |
Why?
|
| Schizophrenia | 1 | 2016 | 6915 | 0.040 |
Why?
|
| Cell Differentiation | 1 | 2014 | 11480 | 0.030 |
Why?
|
| Time Factors | 2 | 2016 | 40133 | 0.030 |
Why?
|
| Body Weight | 1 | 2007 | 4613 | 0.030 |
Why?
|
| Stents | 1 | 2008 | 3303 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2008 | 10829 | 0.030 |
Why?
|
| Learning | 2 | 2015 | 1733 | 0.030 |
Why?
|
| Tissue Fixation | 1 | 2017 | 241 | 0.030 |
Why?
|
| Freezing Reaction, Cataleptic | 1 | 2015 | 41 | 0.030 |
Why?
|
| Miniaturization | 1 | 2015 | 153 | 0.030 |
Why?
|
| Electromagnetic Phenomena | 1 | 2016 | 161 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2010 | 10340 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2014 | 12100 | 0.030 |
Why?
|
| Dependovirus | 1 | 2018 | 708 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2003 | 3726 | 0.030 |
Why?
|
| Depression | 1 | 2012 | 8033 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2008 | 12968 | 0.030 |
Why?
|
| Halorhodopsins | 1 | 2012 | 10 | 0.030 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Kinase | 1 | 2012 | 30 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2008 | 8523 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2008 | 58947 | 0.030 |
Why?
|
| Extinction, Psychological | 1 | 2015 | 371 | 0.030 |
Why?
|
| Mice, Transgenic | 2 | 2015 | 9531 | 0.030 |
Why?
|
| Rats, Long-Evans | 1 | 2012 | 373 | 0.030 |
Why?
|
| Thalamus | 1 | 2018 | 1041 | 0.020 |
Why?
|
| Peripheral Nerves | 1 | 2015 | 475 | 0.020 |
Why?
|
| Nociceptors | 1 | 2015 | 457 | 0.020 |
Why?
|
| Ventral Tegmental Area | 1 | 2012 | 134 | 0.020 |
Why?
|
| Microinjections | 1 | 2012 | 321 | 0.020 |
Why?
|
| Biophysical Phenomena | 1 | 2012 | 320 | 0.020 |
Why?
|
| Biophysics | 1 | 2012 | 380 | 0.020 |
Why?
|
| Optics and Photonics | 1 | 2012 | 305 | 0.020 |
Why?
|
| Somatosensory Cortex | 1 | 2014 | 511 | 0.020 |
Why?
|
| Horses | 1 | 2011 | 299 | 0.020 |
Why?
|
| Nucleus Accumbens | 1 | 2012 | 365 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2008 | 7400 | 0.020 |
Why?
|
| Feedback, Physiological | 1 | 2012 | 476 | 0.020 |
Why?
|
| Pyramidal Cells | 1 | 2011 | 369 | 0.020 |
Why?
|
| Gyrus Cinguli | 1 | 2015 | 1113 | 0.020 |
Why?
|
| User-Computer Interface | 1 | 2015 | 1402 | 0.020 |
Why?
|
| Stress, Psychological | 2 | 2015 | 4440 | 0.020 |
Why?
|
| Temperature | 1 | 2015 | 2221 | 0.020 |
Why?
|
| AIDS Serodiagnosis | 1 | 2009 | 216 | 0.020 |
Why?
|
| Medical Audit | 1 | 2009 | 453 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2012 | 1849 | 0.020 |
Why?
|
| Hypertension | 1 | 2008 | 8595 | 0.020 |
Why?
|
| Motor Cortex | 1 | 2015 | 995 | 0.020 |
Why?
|
| Treatment Outcome | 3 | 2010 | 64947 | 0.020 |
Why?
|
| Equipment Design | 1 | 2015 | 3520 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2008 | 24086 | 0.020 |
Why?
|
| Electric Stimulation | 1 | 2012 | 1735 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2008 | 39254 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2017 | 3764 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2012 | 2671 | 0.020 |
Why?
|
| Evoked Potentials | 1 | 2012 | 1031 | 0.020 |
Why?
|
| Immunoglobulin M | 1 | 2011 | 1529 | 0.020 |
Why?
|
| Heart Failure | 1 | 2010 | 11835 | 0.020 |
Why?
|
| Action Potentials | 1 | 2011 | 1814 | 0.010 |
Why?
|
| Endpoint Determination | 1 | 2006 | 597 | 0.010 |
Why?
|
| Muscle Weakness | 1 | 2006 | 413 | 0.010 |
Why?
|
| Phylogeny | 1 | 2011 | 2775 | 0.010 |
Why?
|
| HIV Infections | 1 | 2009 | 17159 | 0.010 |
Why?
|
| Observer Variation | 1 | 2008 | 2596 | 0.010 |
Why?
|
| Health Resources | 1 | 2008 | 936 | 0.010 |
Why?
|
| Antibodies, Viral | 1 | 2011 | 3145 | 0.010 |
Why?
|
| Reference Values | 1 | 2006 | 4920 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 2012 | 4409 | 0.010 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2010 | 2129 | 0.010 |
Why?
|
| Aged | 2 | 2007 | 168995 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2008 | 5507 | 0.010 |
Why?
|
| Health Care Costs | 1 | 2008 | 3257 | 0.010 |
Why?
|
| Phenotype | 1 | 2012 | 16543 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2008 | 9283 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2008 | 14656 | 0.010 |
Why?
|
| Clinical Competence | 1 | 2008 | 4786 | 0.010 |
Why?
|
| Sex Factors | 1 | 2006 | 10530 | 0.010 |
Why?
|
| Incidence | 1 | 2008 | 21378 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2006 | 15827 | 0.000 |
Why?
|
| Adult | 2 | 2009 | 219847 | 0.000 |
Why?
|